Shram MJ, Schoedel KA, Bartlett C, Shazer RL, Anderson CM, Sellers EM. Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users. Clin Pharmacol Ther 2011; 89(5): 683-692.
Shram MJ, Sellers EM, Romach MK. Oral ketamine as a positive control in human abuse potential studies. Drug Alcohol Depend 2011; 114(2-3): 185-193.
Schoedel KA, McMorn S, Chakraborty B, Potts SL, Zerbe K, Sellers EM. Positive and negative subjective effects of extended-release oxymorphone versus controlled-release oxycodone in recreational opioid users. J Opioid Manag. 2011 May-Jun; 7(3):179-92. PubMed PMID: 21823549.
Schoedel KA, Chen N, Hilliard A, White L, Stott C, Russo E, Wright S, Guy G,Romach MK, Sellers EM. A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use. Hum Psychopharmacol. 2011 Apr;26(3):224-36. doi: 10.1002/hup.1196. PubMedPMID: 21671456.
McMorn S, Schoedel KA, Sellers EM. Effects of low-dose opioids on cognitive dysfunction. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(32):4342-3; author reply 3-4. Epub 2011/10/05.
Shram MJ, Schoedel KA, Bartlett C, Shazer RL, Anderson CM, Sellers EM. Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptoragonist, in recreational polydrug users. Clin Pharmacol Ther. 2011 May; 89(5):683-92. doi: 10.1038/clpt.2011.20. Epub 2011 Mar 16. PubMed PMID:21412231.
Schoedel KA, Chen N, Hilliard A, White L, Stott C, Russo E, Wright S, Guy G,
Romach MK, Sellers EM. A randomized, double-blind, placebo-controlled, crossover
study to evaluate the subjective abuse potential and cognitive effects of
nabiximol oromucosal spray in subjects with a history of recreational cannabis
use. Hum Psychopharmacol. 2011 Jun 13. doi: 10.1002/hup.1196.
[Epub ahead of
print] PubMed PMID: 21671456.
Shram MJ, Schoedel KA, Bartlett C, Shazer RL, Anderson CM, Sellers EM.
Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor
agonist, in recreational polydrug users. Clin Pharmacol Ther. 2011
May;89(5):683-92. Epub 2011 Mar 16. PubMed PMID: 21412231.
